ArticleJournal of neurosurgery. Case lessons2025
Tumor-to-tumor metastasis of clear cell renal cell carcinoma to meningioma: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synchronous tumor-to-tumor metastasis of breast carcinoma to intracranial meningioma: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTumor-to-tumor metastasis (TTM) is an exceptionally rare phenomenon. To date, only 12 cases of the metastasis of clear cell renal cell carcinoma (ccRCC) to a meningioma have been reported in the literature. The authors present a unique case of TTM involving ccRCC metastasizing to a meningioma in a patient with a history of both primary cancers. OBSERVATIONS: A 58-year-old male with a history of 2 primary cancers developed a biphasic tumor diagnosed as TTM of ccRCC to meningioma. The patient initially presented with left lower-extremity (LLE) weakness and underwent subtotal resection of his meningioma. Postsurgical imaging revealed rapid tumor progression, for which the patient completed adjuvant radiotherapy. Concurrently, the patient developed hematuria and was diagnosed with ccRCC. Subsequent recurrent LLE weakness and intracranial tumor progression prompted re-resection, revealing a TTM. LESSONS: In patients with a history of multiple cancers who present with recurrent intracranial disease progression radiographically and/or clinically, it is worth considering TTM in the differential diagnosis to facilitate multidisciplinary workup, management, and treatment. https://thejns.org/doi/10.3171/CASE24670.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.